Abstract: The systems, devices and methods provide customizable and adjustable support to anatomical tissue or organs, such as pelvic, vaginal, uterine, cervical, bladder, rectal, among others, or any combination thereof. The anatomical support device may include a support member having a periphery that surrounds an opening. The support member may be configured to releasably and adjustably expand between one or more expanding states from a resting state and contract to the resting state. The support member may include a first portion and a second portion disposed along the periphery. Each portion may include a passage cross-sectional area and a wall thickness. The first wall thickness and/or the first passage cross-sectional area of the first portion may be different from the second wall thickness and/or the second passage cross-sectional area of the second portion.

Abstract: The systems, devices and methods provide customizable and adjustable support to anatomical tissue or organs, such as pelvic, vaginal, uterine, cervical, bladder, rectal, among others, or any combination thereof. The anatomical support device may include a support member having a periphery that surrounds an opening. The support member may be configured to releasably and adjustably expand between one or more expanding states from a resting state and contract to the resting state. The support member may include a first portion and a second portion disposed along the periphery. Each portion may include a passage cross-sectional area and a wall thickness. The first wall thickness and/or the first passage cross-sectional area of the first portion may be different from the second wall thickness and/or the second passage cross-sectional area of the second portion.

Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.

Abstract: Disclosed are systems and methods for estimating the vitreal half-life of a therapeutic agent. In particular, systems and methods are disclosed for predicting the vitreal half-life of a therapeutic agent conjugated to a polymer that make use of an empirically-derived relationship of vitreal half-life to the hydrodynamic radius of a candidate therapeutic agent-polymer conjugate. The present disclosure is further directed to the use of the systems and methods disclosed herein to design a candidate therapeutic agent-polymer conjugate with a preselected vitreal half-life.

Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.

Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.

Abstract: A system and method for converting website content is presented. Design elements in a graphical representation of a web page are identified. The design elements are ordered according to a position of each of the design elements with respect to a top of the graphical representation of the web page. One or more of the ordered design elements are grouped into one or more groups of design elements, and the design elements are stacked by rearranging each group of design elements into a single column. The single column of the groups of design elements are rendered into a converted web page for display on a device. In one implementation, the device is a mobile device.

Abstract: A system and method for converting website content is presented. Design elements in a graphical representation of a web page are identified. The design elements are ordered according to a position of each of the design elements with respect to a top of the graphical representation of the web page. One or more of the ordered design elements are grouped into one or more groups of design elements, and the design elements are stacked by rearranging each group of design elements into a single column. The single column of the groups of design elements are rendered into a converted web page for display on a device. In one implementation, the device is a mobile device.

Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.

Abstract: A system and method for converting website content is presented. Design elements in a graphical representation of a web page are identified. The design elements are ordered according to a position of each of the design elements with respect to a top of the graphical representation of the web page. One or more of the ordered design elements are grouped into one or more groups of design elements, and the design elements are stacked by rearranging each group of design elements into a single column. The single column of the groups of design elements are rendered into a converted web page for display on a device. In one implementation, the device is a mobile device.

Abstract: A system and method for converting website content is presented. Design elements in a graphical representation of a web page are identified. The design elements are ordered according to a position of each of the design elements with respect to a top of the graphical representation of the web page. One or more of the ordered design elements are grouped into one or more groups of design elements, and the design elements are stacked by rearranging each group of design elements into a single column. The single column of the groups of design elements are rendered into a converted web page for display on a device. In one implementation, the device is a mobile device.

Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.

Abstract: A system and method for converting website content is presented. Design elements in a graphical representation of a web page are identified. The design elements are ordered according to a position of each of the design elements with respect to a top of the graphical representation of the web page. One or more of the ordered design elements are grouped into one or more groups of design elements, and the design elements are stacked by rearranging each group of design elements into a single column. The single column of the groups of design elements are rendered into a converted web page for display on a device. In one implementation, the device is a mobile device.

Abstract: A system and method for converting website content is presented. Design elements in a graphical representation of a web page are identified. The design elements are ordered according to a position of each of the design elements with respect to a top of the graphical representation of the web page. One or more of the ordered design elements are grouped into one or more groups of design elements, and the design elements are stacked by rearranging each group of design elements into a single column. The single column of the groups of design elements are rendered into a converted web page for display on a device. In one implementation, the device is a mobile device.

Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.

Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.

Abstract: A computing device that includes a host processor and a service processor is provided. The host processor is configured to interact with a first user interface. For example, the host processor may be a microprocessor for the device and the first user interface may be a display device. A service processor is provided and can interact with a second user interface. In some cases, the service processor may interact with the second user interface without communicating with the host processor. Accordingly, the service processor can perform functions without relying on the host processor. Using the service processor conserves processing power and also may allow the reduction in size of the device as the service processor may perform the functions previously performed by discrete hardware and the host processor.

Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.

Abstract: The invention relates to anti-Factor D antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their production and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.

Abstract: A single line docking station characteristic identifier is disclosed. In one embodiment, a portable computing device can include a dock detector circuit having an interface pin configured to be coupled to a docking station via a single line dock connection, where the dock detector circuit is configured to determine a characteristic of the docking station using a passive component in the docking station when the portable computing device is connected to the docking station via the single line dock connection. The dock detector circuit can include a resistor and a Schmitt trigger, while the passive component in the docking station can include a capacitor, for example.